发明公开
EP1585731A2 HISTAMINE H3 RECEPTOR ANTAGONISTS, PREPARATON AND THERAPEUTIC USES
审中-公开
组胺H3受体拮抗剂，制备和治疗用途
- 专利标题： HISTAMINE H3 RECEPTOR ANTAGONISTS, PREPARATON AND THERAPEUTIC USES
- 专利标题（中）： 组胺H3受体拮抗剂，制备和治疗用途
-
申请号： EP03749068.7申请日： 2003-09-12
-
公开(公告)号： EP1585731A2公开(公告)日： 2005-10-19
- 发明人: BEAVERS, Lisa, Selsam , FINLEY, Don, Richard , GADSKI, Robert, Alan , HIPSKIND, Philip, Arthur , JESUDASON, Cynthia, Darshini , PICKARD, Richard, Todd , STEVENS, Freddie, Craig , SEIDAM ,Christopher ,Stephen
- 申请人： ELI LILLY AND COMPANY
- 申请人地址： Lilly Corporate Center Indianapolis, Indiana 46285 US
- 专利权人： ELI LILLY AND COMPANY
- 当前专利权人： ELI LILLY AND COMPANY
- 当前专利权人地址： Lilly Corporate Center Indianapolis, Indiana 46285 US
- 代理机构： Kingsbury, Oliver William
- 优先权： US411625P 20020918
- 国际公布： WO2004026837 20040401
- 主分类号： C07D215/08
- IPC分类号： C07D215/08 ; C07D215/20 ; C07D215/06 ; C07D215/58 ; C07D215/227 ; C07D209/26 ; C07D209/04 ; C07D209/24 ; C07D209/22 ; A61K31/404 ; A61K31/47 ; A61P37/00
摘要：
The present invention discloses novel compounds of Formula ( I ) or pharmaceutically acceptable salts thereof which have histamine-H3 receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I), as well as methods of using them to treat obesity and other histamine H3 receptor-related diseases.
信息查询
